Abbott Laboratories (ABT) earnings · P/E 25, rev $44.33B
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
This ABT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
When the next ABT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for ABT. We will not invent a beat or miss.
Not investment advice. Full ABT research stays on the stock page; the tape stays on the quote page.
Not investment advice.